Zobrazeno 1 - 9
of 9
pro vyhledávání: '"S A, Lyalkin"'
Autor:
N V, Dovganych, S M, Kozhukhov, I I, Smolanka, O F, Lygyrda, O Ye, Bazyka, S A, Lyalkin, O M, Ivankova, O A, Yarynkina, N V, Tkhor
Publikováno v:
Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology. 27:440-454
Breast cancer patients (BC) have a high risk of cardiotoxicity (CT) due to a combination of cancer treatments.Cardiovascular (CV) complications lead to delay or withdrawal of BC therapy and worsen the survival. Therefore, it isimportant to detect CT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e3dbf29fe154eab7e09185dba6f4c1
https://doi.org/10.33145/2304-8336-2022-27-440-454
https://doi.org/10.33145/2304-8336-2022-27-440-454
Publikováno v:
Experimental oncology. 44(3)
The aim of the study was to examine the prognostic value of immunobiological markers (tumor-infiltrating lymphocytes (TILs) and their subpopulations) in residual tumor after neoadjuvant chemotherapy (NACT) completion in patients with triple negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272b0bbe49925451b78341e78e648353
https://pubmed.ncbi.nlm.nih.gov/36325708
https://pubmed.ncbi.nlm.nih.gov/36325708
Autor:
S M, Kozhukhov, N V, Dovganych, I I, Smolanka, O F, Lygyrda, O Ye, Bazyka, S A, Lyalkin, O M, Ivankova, O A, Yarinkina, N V, Tkhor
Publikováno v:
Problemy radiatsiinoi medytsyny ta radiobiolohii. 26
Breast cancer patients receive combined antitumor treatment (surgery, chemotherapy, targeted drugs and radia-tion), so they are considered to be the patients with potentially high risk of cardiotoxicity (CT). Risk stratificationof cardiovascular comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7b3e117b56d97220c34a7e082d64ba8
https://pubmed.ncbi.nlm.nih.gov/34965569
https://pubmed.ncbi.nlm.nih.gov/34965569
Autor:
L. A. Sivak, A. N. Grabovyj, N. O. Verovkina, S. A. Lyalkin, N. M. Majdanevych, A. V. Askolskyy, M. Yu. Klimanov
Publikováno v:
Likarska sprava. :83-88
Традиционно рак молочной железы (РМЖ) не рассматривают как типично иммуногенную опухоль. Тем не менее известно, что РМЖ является гетерог
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d40283be04aaa6b9f9f4c6ea80baa3e5
https://doi.org/10.31640/ls-2017(1-2)12
https://doi.org/10.31640/ls-2017(1-2)12
Publikováno v:
Likarska sprava. :73-77
Вивчення літературних джерел свідчить про те, що за останні 20 років нудота та блювання залишаються двома основними побічними ефектами х
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::798ebe8e8188bc67f71d93091d480a4a
https://doi.org/10.31640/ls-2016(5-6)13
https://doi.org/10.31640/ls-2016(5-6)13
Publikováno v:
Likarska sprava. :3-11
Індукована хіміотерапією периферична нейропатія (ІХПН) є одним з основних дозолімітуючих побічних ефектів багатьох широко використову
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cdacdfb82e3a958c3f5472966c50086
https://doi.org/10.31640/ls-2016(3-4)01
https://doi.org/10.31640/ls-2016(3-4)01
Publikováno v:
Bulletin of Problems Biology and Medicine. 2:124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1651ccd81f0a63663ef66bb7725b918
https://doi.org/10.29254/2077-4214-2020-2-156-124-128
https://doi.org/10.29254/2077-4214-2020-2-156-124-128
Autor:
L A, Syvak, H O, Hubareva, K S, Filonenko, N M, Majdanevych, O M, Aleksyk, S A, Lyalkin, M J, Klimanov, A V, Askolskyi, N V, Kasap
Publikováno v:
Likars'ka sprava. (3-4)
The use of modern chemotherapy (CT) allowed to achieve significant progress in the treatment of many malignant tumors that were previously considered fatal. Improving the efficiency of the treatment was achieved by the intensification of chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::891288ae09ad6727ee24585413f255ed
https://pubmed.ncbi.nlm.nih.gov/26827433
https://pubmed.ncbi.nlm.nih.gov/26827433
Autor:
L A, Sivak, N N, Maidanevich, S A, Lyalkin, E M, Aleksik, A V, Askolskiy, M Y, Klimanov, N V, Kasap
Publikováno v:
Likars'ka sprava. (1-2)
Chemotherapy in modern oncology is one of the main methods of treatment, along with surgery and radiotherapy techniques. More than 60% of patients receiving chemotherapy at different stages of treatment. Recently, modern chemotherapy has become more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::89118a9c4042b6e4334c8e13c81c4b78
https://pubmed.ncbi.nlm.nih.gov/26118038
https://pubmed.ncbi.nlm.nih.gov/26118038